Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Crinone

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Progesterone
Progesterone 0.08 MG/MG Vaginal Gel [Crinone]analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study…
OBJECTIVE To compare the efficacy of Crinone vaginal gel and intramuscular progesterone (IMP) for luteal phase support in in… 
2008
2008
Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized…
This study was performed to compare the efficacy of Crinone 8% intravaginal gel and intramuscular progesterone (IMP… 
Highly Cited
2007
Highly Cited
2007
Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
OBJECTIVE To compare the efficacy and tolerability of two different types of vaginal progesterone (P), Crinone 8% gel (Fleet… 
  • table 1
  • table 2
  • figure 1
Highly Cited
2005
Highly Cited
2005
Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
OBJECTIVE To demonstrate the comparative efficacy and tolerability of capsules containing 200 mg of P (Utrogest 200) or Crinone 8… 
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Highly Cited
2002
Highly Cited
2002
Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study.
The Crinone 8% preparation makes it possible to administer natural progesterone (90 mg) vaginally once daily for luteal phase… 
Highly Cited
2001
Highly Cited
2001
A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles.
OBJECTIVE To compare the efficacy of Crinone 8% intravaginal progesterone gel vs. IM progesterone for luteal phase and early… 
Highly Cited
2000
Highly Cited
2000
Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3).
OBJECTIVE Compare the pharmacokinetics of vaginal progesterone gel (Crinone 8%, 90 mg) with that of oral progesterone (Prometrium… 
  • table 1
1999
1999
Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer.
OBJECTIVE To evaluate the outcome of IVF-ET after the use of Crinone 8% (Wyeth-Ayerst Laboratories, Inc., Philadelphia, PA… 
Highly Cited
1999
Highly Cited
1999
Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.
OBJECTIVE To investigate the efficacy and safety of intravaginal Crinone 8% (Columbia Research Laboratories, Miami. FL) versus IM… 
Highly Cited
1996
Highly Cited
1996
Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone.
Two progesterone presentations, a vaginal application of 90 mg progesterone per day (Crinone) or 300 mg progesterone administered… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE